Cargando…

New Insights Into the Management of Diabetic Retinopathy

Detalles Bibliográficos
Autor principal:	Abu El-Asrar, Ahmed M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841943/ https://www.ncbi.nlm.nih.gov/pubmed/24339675 http://dx.doi.org/10.4103/0974-9233.119991

Ejemplares similares

New Developments in the Pathophysiology and Management of Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Endothelial-to-mesenchymal transition contributes to the myofibroblast population in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M.
Publicado: (2016)

Evolving Strategies in the Management of Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M
Publicado: (2013)

Role of Inflammation in the Pathogenesis of Diabetic Retinopathy
por: El-Asrar, Ahmed M. Abu
Publicado: (2012)

Insulin Signaling Via Retinal Pericytes, New Insights and Potential Implications in Diabetic Retinopathy
por: Aldibbiat, Ali M
Publicado: (2021)

Commentary: Oral management of diabetic retinopathy
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Clocking in on Diabetic Retinopathy
por: Kleinman, Mark E., et al.
Publicado: (2013)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Diabetic Retinopathy in 2011: Further Insights From New Epidemiological Studies and Clinical Trials
por: Lamoureux, Ecosse L., et al.
Publicado: (2011)

Commentary: Burden of diabetic retinopathy
por: Bhattacharjee, Harsha, et al.
Publicado: (2021)

Need for a New Classification of Diabetic Retinopathy
por: Jampol, Lee M., et al.
Publicado: (2021)

Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Antagonizing Wnt Pathway in Diabetic Retinopathy
por: Zhao, Ling, et al.
Publicado: (2013)

Novel strategy for screening of diabetic retinopathy
por: Takagi, Hitoshi
Publicado: (2017)

Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M, et al.
Publicado: (2014)

Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2022)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

Commentary: From diabetic retinopathy toward diabetic retinal disease
por: Saurabh, Kumar, et al.
Publicado: (2021)

Commentary: Diabetic retinopathy and its correlation with other diabetic complications
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017)

The Role of Glycemic Control and Variability in Diabetic Retinopathy
por: Chatziralli, Irini P.
Publicado: (2017)

Commentary: Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy
por: Rana, Vipin, et al.
Publicado: (2021)

Cellular Mechanisms of High Mobility Group 1 (HMGB-1) Protein Action in the Diabetic Retinopathy
por: Santos, Andrea Rachelle C., et al.
Publicado: (2014)

Curious relationship between cognitive impairment and diabetic retinopathy
por: Kawamura, Takahiko, et al.
Publicado: (2015)

Diabetic retinopathy classification for supervised machine learning algorithms
por: Nakayama, Luis Filipe, et al.
Publicado: (2022)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Apolipoproteins and Diabetic Retinopathy
por: Chait, Alan, et al.
Publicado: (2011)

Diabetic retinopathy in Africa
por: Bascaran, Covadonga, et al.
Publicado: (2022)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Intravitreal Inflammation: From Benchside to Bedside
por: Romano, Mario R., et al.
Publicado: (2013)

(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
por: Wilkinson-Berka, Jennifer L., et al.
Publicado: (2009)

Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017)

Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India
por: Misra, Neha, et al.
Publicado: (2020)

Commentary: Predictors of development and progression of diabetic retinopathy: A precis
por: Moharana, Bruttendu, et al.
Publicado: (2021)

Commentary: Shifting our focus to diabetic retinopathy is the need of the hour
por: Kohli, Piyush, et al.
Publicado: (2022)

New Insights on Dietary Polyphenols for the Management of Oxidative Stress and Neuroinflammation in Diabetic Retinopathy
por: Fanaro, Gustavo Bernardes, et al.
Publicado: (2023)

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Paradigm shift – For effective management of diabetic retinopathy and glaucoma
por: Ravilla, Thulasiraj
Publicado: (2018)

New Horizons in Research on Diabetic Complications of the Eye: Special Emphasis on Diabetic Cataracts and Retinopathy
por: Hegde, Kavita R., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_svoajv5enbi18civ02u4a3ct9i